Abstract
Background: Bone metastases from non-small cell lung cancer pose a significant threat to elderly patients, with a certain number succumbing to this condition annually. For patients who have experienced tumor reduction post-chemotherapy, the dilemma of whether to continue chemotherapy or not becomes a confounding factor in the medical decision-making process for their families, considering the ability of elderly patients to tolerate further chemotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
